Addition of bevacizumab to EGFR tyrosine kinase inhibitors in advanced NSCLC: an updated systematic review and meta-analysis

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC10807044 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature